Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Taku Hirabayashi"'
Autor:
Michiko Nishikawa, Yoshinobu Yamamoto, Saeko Kushida, Taku Hirabayashi, Syunta Tanaka, Naoki Takegawa, Takuya Mimura, Hidetaka Tsumura, Ikuya Miki, Masahiro Tsuda
Publikováno v:
DEN Open, Vol 3, Iss 1, Pp n/a-n/a (2023)
Abstract Objectives Chemoradiotherapy (CRT) or radiotherapy (RT) alone is often the treatment of choice for elderly patients with esophageal cancer with the expectation of organ preservation. However, salvage treatment remains a problem when endoscop
Externí odkaz:
https://doaj.org/article/031b8416d54340139c2380e795fd49f5
Autor:
Naoki Takegawa, Taku Hirabayashi, Shunta Tanaka, Michiko Nishikawa, Nagahiro Tokuyama, Takuya Mimura, Saeko Kushida, Hidetaka Tsumura, Yoshinobu Yamamoto, Ikuya Miki, Masahiro Tsuda
Publikováno v:
PLoS ONE, Vol 18, Iss 5, p e0285365 (2023)
Although phase III trials have reported improved overall survival in patients with advanced esophageal squamous cell carcinoma following treatment with nivolumab, as compared with chemotherapy (paclitaxel or docetaxel), the treatment was effective on
Externí odkaz:
https://doaj.org/article/3c58d9e7e03440a2a26429525c5507ce
Autor:
Michiko Nishikawa, Yoshinobu Yamamoto, Saeko Kushida, Taku Hirabayashi, Syunta Tanaka, Naoki Takegawa, Takuya Mimura, Hidetaka Tsumura, Ikuya Miki, Masahiro Tsuda
Publikováno v:
DEN open. 3(1)
Chemoradiotherapy (CRT) or radiotherapy (RT) alone is often the treatment of choice for elderly patients with esophageal cancer with the expectation of organ preservation. However, salvage treatment remains a problem when endoscopic resection is not